There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Show figures in :Show figures in :
Data is unavailable
Data is unavailable
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net worth | 32653.32 | 29842.80 | 26839.85 | 24575.98 | 21929.87 | 16824.67 | 13890.78 | 11680.42 | 9371.91 | 7287.30 | 5155.91 | 3750.15 | 2605.76 | 2339.65 | 2444.83 | 1829.08 | 1241.26 |
| Fixed assets | 14794.19 | 14492.79 | 11023.69 | 10532.09 | 9373.58 | 9396.47 | 8474.85 | 6520.68 | 4833.78 | 4179.69 | 3705.64 | 2721.67 | 2638.87 | 2194.65 | 1738.60 | 1710.85 | 1398.77 |
| Debt | 7941.68 | 6315.22 | 4861.52 | 2372.77 | 4972.27 | 5561.97 | 6966.76 | 4769.93 | 3364.14 | 5041.07 | 4451.07 | 3769.14 | 3435.46 | 3095.94 | 2414.25 | 2154.56 | 2332.97 |
View detailed balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 3924.62 | 2434.52 | 2386.75 | 5016.48 | 3329.05 | 4381.28 | 1650.97 | 1954.52 | 3278.58 | 1419.76 | 1236.81 | 646.28 | 274.87 | 326.25 | 335.11 | 425.18 | 136.03 |
| Investing | -1875.80 | -4255.95 | -3977.75 | -3211.56 | 598.69 | -1567.64 | -2902.59 | -1926.59 | -1787.04 | -1445.21 | -1397.97 | -818.74 | -246.34 | -563.16 | -599.07 | -399.02 | -406.28 |
| Financing | 119.78 | 800.42 | 1814.41 | -2969.27 | -1364.94 | -1947.18 | 1919.06 | 864.15 | -1915.26 | 365.44 | 93.21 | 117.64 | 108.09 | 118.85 | 406.98 | -84.04 | 164.99 |
Aurobindo Pharma operates as a company which develops and produces generic and specialty pharmaceuticals and injectables and APIs while expanding its business into respiratory and nasal products and biosimilars and biologics contract manufacturing services.
The company operates in 151 countries through its manufacturing sites and marketing centers located in India and the USA and Europe and key Growth Markets.
